Journal of Leukemia & Lymphoma 2019;28(11):698-701

doi:10.3760/cma.j.issn.1009-9921.2019.11.016

Progress of blastic plasmacytoid dendritic cell neoplasms

Xiuping WANG 1 ; Jingyun SHI 2 ; Tao WU 1 ; Hai BAI 1

Affiliations

+expand

Keywords

Hematologic neoplasms; Blastic plasmacytoid dendritic cell neoplasm; Molecular targeted therapy; Hematopoietic stem cell transplantation; Combined modality therapy

Country

China

Language

Chinese

Abstract

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a kind of highly malignant tumor in the hematological system, which is characterized with low incidence, diverse clinical manifestations, strong invasiveness and poor prognosis, however, currently there has no standard treatment yet. This paper reviews the recent research progress of BPDCN.